Anti-inflammatory drug improves survival in COVID-19 patients
Researchers from 68 sites across the country, led by David E. Leaf and Shruti Gupta from the Division of Renal Medicine at Harvard-affiliated Brigham and Women’s Hospital, have investigated the effects of the anti-inflammatory drug tocilizumab on critically ill patients with laboratory-confirmed COVID-19. Unlike steroids, which suppress the immune system more broadly, tocilizumab specifically inhibits the receptor for… Read More »